bioAffinity Technologies, Inc. (BIAF) Financial Statements

215 Followers

bioAffinity Technologies, Inc. Financial Overview

bioAffinity Technologies, Inc.'s market cap is currently $11.18M. The company's EPS TTM is $5.98; its P/E ratio is -0.14; bioAffinity Technologies, Inc. is scheduled to report earnings on March 13, 2026, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 25	Mar 25	Mar 24	Dec 22	Dec 21
Income Statement
Total Revenue	$ 6.16M	$ 9.36M	$ 2.53M	$ 4.80K	$ 0.00
Gross Profit	$ 1.43M	$ 3.38M	$ 791.62K	$ 4.34K	$ -4.82K
Operating Income	$ -10.57M	$ -8.95M	$ -7.97M	$ -4.01M	$ -2.21M
EBITDA	$ -10.07M	$ -8.33M	$ -7.63M	$ -5.61M	$ -5.32M
Net Income	$ -14.91M	$ -9.04M	$ -7.94M	$ -8.15M	$ -6.33M
Balance Sheet
Cash & Short-Term Investments	$ 6.45M	$ 1.11M	$ 2.82M	$ 11.41M	$ 1.36M
Total Assets	$ 10.96M	$ 6.51M	$ 8.22M	$ 12.18M	$ 1.45M
Total Debt	$ 1.16M	$ 1.50M	$ 1.58M	$ 251.75K	$ 11.36M
Net Debt	$ -5.29M	$ 395.90K	$ -1.24M	$ -11.16M	$ 10.00M
Total Liabilities	$ 3.68M	$ 3.91M	$ 3.37M	$ 1.14M	$ 17.24M
Stockholders' Equity	$ 7.28M	$ 2.60M	$ 4.86M	$ 11.04M	$ -15.79M
Cash Flow
Free Cash Flow	$ -9.39M	$ -7.34M	$ -6.06M	$ -4.29M	$ -2.05M
Operating Cash Flow	$ -9.33M	$ -7.26M	$ -6.04M	$ -4.07M	$ -2.05M
Investing Cash Flow	$ -60.57K	$ -79.08K	$ -2.21M	$ -219.99K	$ 0.00
Financing Cash Flow	$ 14.73M	$ 5.63M	$ -344.98K	$ 14.34M	$ 3.33M

Currency in USD

bioAffinity Technologies, Inc. Earnings and Revenue History

Income Statement >

bioAffinity Technologies, Inc. Debt to Assets

Balance Sheet >

bioAffinity Technologies, Inc. Cash Flow

Cash Flow >

bioAffinity Technologies, Inc. Forecast EPS vs Actual EPS

Earnings >